Testicular Cancer Doctors in Turkey — Page 2

Professor Sezer Saglam is a leading medical oncologist at Istanbul Florence Nightingale Hospital with senior expertise in managing complex malignancies.

• Specialises in medical oncology at a JCI-accredited centre of excellence
• Member of the European Society for Medical Oncology (ESMO)
• Member of the American Society of Clinical Oncology (ASCO)
• Completed specialized training at the Istanbul University Oncology Institute
• Experienced in coordinating multidisciplinary care for clinical oncology cases

Dr. Ahmet Belici is an experienced medical oncologist with 20+ years of experience specializing in sarcoma and lung cancer treatments.

Tahsin Ozadli is a medical oncology specialist who trained at the Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital – one of Turkey's premier cancer centres.

• Focuses on medical oncology for complex solid tumours and urological malignancies
• Experienced in treating gastrointestinal cancers including oesophageal and gastric cases
• Holds a research profile at Selcuk University Meram Faculty of Medicine
• Practises at Valued Med Hub Hospitals using evidence-based systemic therapies

Professor Selami Albayrak leads the urology department at Medipol Mega University Hospital – one of Turkey's largest private medical facilities. He holds a senior academic position as a professor at Istanbul Medipol University.

• Treats urological cancers including testicular and prostate cases
• Performs robot-assisted surgery for precision and faster patient recovery
• Recognised by the Turkish Urology Association
• Focuses on kidney transplantation and oncological urology
• Coordinates multidisciplinary care for patients with complex cancers

Dr Saban Sec is a respected medical oncologist at Valued Med Hub Hospitals who leads the representative body for specialists within the Turkish Medical Oncology Association.

• Specialises in urogenital cancers, including targeted management for testicular and prostate malignancies
• Expert in managing rare tumours and complex sarcomas using evidence-based chemotherapy protocols
• Active researcher in metabolic tumour volume and prognostic markers to predict patient treatment responses
• Member of the Istanbul Medical Chamber and the Turkish Medical Oncology Association

Professor Ozcan Yildiz is a senior medical oncologist at Medipol Mega University Hospital with a strong track record in treating rare and complex germ cell tumours.

• Specialises in managing dysgerminoma and gestational choriocarcinoma tumours
• Focuses on gastroenteropancreatic neuroendocrine tumours and metastatic cases
• Actively contributes to international oncology research with over 15 published peer-reviewed studies
• Expert in managing paraneoplastic syndromes – secondary conditions caused by a patient's immune response to cancer

Professor Turkan Ozturk Topcu brings deep clinical expertise to testicular cancer care at Valued Med Hub Hospitals, having trained at three of the world's most prestigious oncology centres.

• Trained at the MD Anderson Cancer Center in the USA, a global leader in cancer research
• Completed specialist medical oncology training at the Karadeniz Technical University Faculty of Medicine
• Specialises in chemotherapy and targeted systemic treatments for urogenital tumours
• Collaborated with international experts at the Moffitt Cancer Center in Florida

The doctor is an oncologist specializing in the treatment of breast, lung, and gastrointestinal cancers. Currently, the doctor practices at Istinye Liv University Hospital.

With a career spanning multiple esteemed institutions, the doctor has served as an Internal Medicine Specialist at Malatya State Hospital, a physician at Ankara Oncology Clinic, and a member of the Oncology Department at Erzurum Regional Training and Research Hospital.

The doctor graduated from the Faculty of Medicine at Selcuk University and achieved the title of Associate Professor in 2016.

Associate Professor Dr. Yusuf AÇIKGÖZ
Specialization: Medical Oncology

Education:

• 2004-2011: İnönü University Faculty of Medicine
• 2011-2016: Ankara Numune Training and Research Hospital, Internal Medicine
• 2017-2022: Health Sciences University, Medical Oncology

Professional Experience:

• 2016-2017: Bingöl City Hospital, Internal Medicine
• 2021-2022: Health Sciences University, Medical Oncology
• 2022-2023: Kastamonu Education and Research Hospital, Medical Oncology
• 2023-2024: Ohio State University, Medical Oncology
• 2024-Present: Lokman Hekim University, Medical Oncology, Ankara Hospital

Clinical Trials, Courses, Certifications:

Clinical Trials:

• 2017-2021: Phase III, CheckMate-649 Study (Assistant Investigator)
• 2022-Present: Phase III, Fortitude-101 Study (Assistant Investigator)

Courses:

• 2018: Medicres Basic and Advanced Biostatistics Training Program (ongoing), Istanbul-Vienna
• 2019: Immuno-Oncology Education Course, March 1-2, 2019, Vienna, Central European Cooperative Oncology Group (CECOG)
• 2018: Good Clinical Practice Certification, April 7-8, 2018, Ankara, Health Sciences University
• 2017: Basic Oncology Training Program, November 25-26, 2017, Adana, Clinical Oncology Society
• 2016: Basic Ultrasonography Course (10 hours theoretical + 10 hours practical), September 24-25, 2016, Ankara, Turkish Emergency Medicine Association

Certifications:

• Ongoing: ECFMG Certification
• 2024: CITI Responsible Conduct of Research (The Ohio State University)
• 2024: CITI IACUC-Laboratory Animal Research (The Ohio State University)
• 2024: CITI Human Subjects Protection (The Ohio State University)
• 2024: CITI Good Clinical Practice (The Ohio State University)
• 2023: Occupational English Test (OET)
• 2019: International English Language Testing System (IELTS), Total Score: 6.5, May 26, 2019, Ankara, British Council
• 2017: USMLE Step 2 CK Exam; Score: 244, February 7, 2017
• 2016: USMLE Step 1 Exam; Score: 215, August 25, 2016

Memberships:

• American Society of Clinical Oncology (ASCO) - 2022
• Turkish Society of Medical Oncology - 2020

Professor Cemil Bilir is a leading medical oncologist at VM Medical Park Pendik Hospital with clinical training from the prestigious Cleveland Clinic.

• Specialises in systemic therapy for testicular cancer using evidence-based protocols
• Holds a PhD in Inorganic Chemistry, focusing on how drugs interact at a molecular level
• Fellowship-trained at Northeastern University's Center for Pharmaceutical Biotechnology and Nanomedicine
• Member of the American Society of Clinical Oncology and European Society for Medical Oncology
• Former Head of Medical Oncology at Sakarya University Faculty of Medicine

Associate Professor Nail Paksoy is an ESMO board-certified medical oncologist specialising in complex systemic therapies for urological cancers. He currently leads oncology cases at Medipol Bahcelievler University Hospital.

• Holds European Society for Medical Oncology (ESMO) board certification in medical oncology
• Subinvestigator for numerous international clinical trials involving targeted immunotherapy drugs
• Specialises in managing metastatic cases and drug-resistant solid tumours
• Active member of the Turkish Society of Medical Oncology
• Published extensive research on prognostic factors and survival outcomes in urological cancers

Education and Specialization

• 2006: Kocaeli University Faculty of Medicine
• 2014: Akdeniz University Faculty of Medicine, Internal Medicine
• 2018: Akdeniz University Faculty of Medicine, Medical Oncology

Experience

• 2006 - 2008: Konya Derebucak District Hospital
• 2009 - 2015: Akdeniz University Hospital
• 2015: Antalya Kaş State Hospital
• 2015 - 2016: İnönü University Faculty of Medicine
• 2016 - 2021: Akdeniz University Hospital
• 2021 - 2023: Antalya Training and Research Hospital

Associate Professor Ercan Ozden is a medical oncology specialist at VM Medical Park Pendik Hospital with deep foundations in internal medicine.

• Specialised in medical oncology at Kocaeli University's Faculty of Medicine
• Completed a residency in internal medicine at Istanbul University's Cerrahpaşa Faculty of Medicine
• Trained in the comprehensive English Medical Programme at Istanbul University
• Focuses on systemic treatments including chemotherapy and targeted drug therapies
• Manages complex cases within a high-volume hospital setting in Istanbul

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Professor Serkan Deveci is a senior urologist at Medical Park Göztepe, specialising in the complex long-term recovery of patients following testicular cancer treatment.

• Expert in retroperitoneal lymph node dissection (RPLND) outcomes, a critical surgery for advanced testicular cancer
• Focuses on managing post-chemotherapy side effects, including nerve-sparing techniques to preserve reproductive function
• Highly active in international research with over 600 citations in leading urological journals
• Member of the American Urological Association and the European Association of Urology

Professor Orhan Tanriverdi is a specialist in uro-oncology at Liv Hospital Ulus, focusing on the management of urological tumours through minimally invasive techniques.

• Specialises in robot-assisted laparoscopic surgery for more precise tumour removal with less downtime
• Offers endourological procedures – uses naturally occurring body openings to avoid large surgical incisions
• Member of the American Urological Association and the European Association of Urology
• Published 31 international research papers on surgical outcomes in urological oncology
• Fellow of the Turkish Association of Urology and the Endourology Society

Professor Turkan Ozturk Topcu is an expert medical oncologist at Biruni University Hospital who completed international research training at the MD Anderson Cancer Center in the USA.

• Specialises in chemotherapy and targeted systemic therapies for testicular cancer
• Participated in oncology research at the Sunnybrook Odette Cancer Center in Canada
• Recognised by the American Society of Clinical Oncology (ASCO)
• Member of the European Society for Medical Oncology (ESMO)
• Focuses on precise treatment planning for varied urological tumours